Axcelead Drug Discovery Partners
Axcelead Drug Discovery Partners, Inc. (ADDP) is the first integrated drug discovery solution provider in Japan, which took over Takeda’s drug discovery platform business in 2017.
ARCALIS is a contract development and manufacturing organization (CDMO) focused on mRNA vaccines and therapeutics.
PassPort Technologies, Inc.
PassPort is a biotechnology company that aims to provide more value in the healthcare market through the development of novel therapeutic systems using “PassPort System”, a new drug delivery technology in combination with a microporation device that creates micropores on the skin surface and dry-patch technologies that controls a delivery of both small molecule and biologics via micropores.
Whiz Partners, Inc. (Tokyo, Japan) is an alternative asset management firm with Growth Equity and Global Macro Hedge fund offerings.